FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to therapeutic dentistry - diseases of oral cavity mucosa, and can be used for determination of degree of severity of changes in microbiota of oral cavity, small and large intestine in patients with licje ruber planus of oral cavity mucosa with hepatobiliary disorders, with exception of hepatitis, exacerbations of hepatobiliary system and pancreas. Essence of the method: markers of microorganisms are detected in samples of saliva, blood and feces for said category of patients by means of method of gas chromatography and mass-spectrometry. If in each of biosamples values of concentrations of detected markers of certain microorganisms or at least one of them increase in certain multiplicity in comparison with the average values of the same indices of control group, degrees of severity of changes in microbiota of oral cavity, small and large intestine in said category of patients are determined.
EFFECT: invention ensures determination of degree of severity of changes in microbiota of oral cavity, small and large intestine in patients with licje ruber planus of oral cavity mucosa.
5 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF ORAL MUCOSA LICHEN PLANUS DEVELOPMENT FOR PATIENTS WITH HEPATOBILIARY DISORDERS AND HYPERCHOLESTEROLEMIA WITH ELEVATED LDL CHOLESTEROL IN ABSENCE OF ORAL MUCOSA LICHEN PLANUS DURING EXAMINATION | 2016 |
|
RU2613667C1 |
METHOD FOR ASSESSING PROBABILITY OF PROGRESSION OF CLINICAL COURSE OF ORAL LICHEN PLANUS IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND HEPATOBILIARY DISORDERS | 2014 |
|
RU2558048C1 |
METHOD FOR DIAGNOSING ORAL DYSBIOSIS | 2021 |
|
RU2782992C1 |
METHOD FOR THE TREATMENT OF CHRONIC GENERALIZED PERIODONTITIS OF MODERATE SEVERITY IN PATIENTS WITH COMORBID PATHOLOGY | 2022 |
|
RU2789345C1 |
METHOD FOR ASSESSING DEGREE OF SEVERITY OF ORAL MUCOSAL OXIDATIVE CHANGES IN PATIENTS WITH ORAL LICHEN ACUMINATIS WITH UNDERLYING LIPID STORAGE DISEASE | 2012 |
|
RU2494397C1 |
ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON BACTERIAL STRAIN | 2015 |
|
RU2616899C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF ORAL DYSBIOSIS IN PATIENTS WITH CROHN'S DISEASE OR ULCERATIVE COLITIS | 2023 |
|
RU2813431C1 |
METHOD OF DIAGNOSTICS OF ORAL CAVITY DYSBIOSIS IN PATIENTS WITH METABOLIC SYNDROME OR TYPE 2 DIABETES MELLITUS | 2023 |
|
RU2813065C1 |
HEPATOPROTECTIVE PROBIOTIC AGENT | 2006 |
|
RU2310463C1 |
METHOD OF TREATING LICHEN ACUMINATUS IN ORAL MUCOSA | 2011 |
|
RU2510269C2 |
Authors
Dates
2017-04-04—Published
2016-01-12—Filed